Vineet Laboratories Limited (BOM:543298)
India · Delayed Price · Currency is INR 36.37
-1.47 (-3.88%)
At close: Oct 6, 2026
Vineet Laboratories Revenue
In the fiscal year ending March 31, 2026, Vineet Laboratories had annual revenue of 595.05M INR, down -22.67%. Vineet Laboratories had revenue of 189.21M in the quarter ending March 31, 2026, with 22.63% growth.
Revenue
595.05M
Revenue Growth
-22.67%
P/S Ratio
1.18
Revenue / Employee
10.44M
Employees
57
Market Cap
703.91M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 595.05M | -174.48M | -22.67% |
| Mar 31, 2025 | 769.53M | -740.11M | -49.03% |
| Mar 31, 2024 | 1.51B | -613.29M | -28.89% |
| Mar 31, 2023 | 2.12B | 211.21M | 11.05% |
| Mar 31, 2022 | 1.91B | -523.07M | -21.48% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Smruthi Organics | 1.12B |
| Kimia Biosciences | 1.12B |
| Panchsheel Organics | 1.08B |
| Tyche Industries | 500.33M |
| Auro Laboratories | 367.34M |
| Vasundhara Rasayans | 350.94M |
| Crestchem | 338.33M |
| Krebs Biochemicals & Industries | 252.34M |